ReviewVox sanguinis2026
An innovative modelling proposal for the blood supply chain.
Review in Vox sanguinis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An innovative modelling proposal for the blood supply chain.Vox sanguinis · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Whole-blood donation and apheresis are the only ways to obtain blood components for human use. Tools are being developed to improve the efficiency of blood donation systems by reducing waste, increasing donations and preventing shortages. These tools also help manage the storage and distribution challenges posed by blood products with different expiry dates. The proposed approach focuses on identifying inefficiencies in the 'blood transfusion chain' and presents a renewed, practical model that differs from other theoretical ones. It outlines 11 processes across three periods: before donation (promotion), during donation and after blood processing. The goal is to optimize each process, reduce inefficiencies and propose improvements based on current scientific knowledge. While changes to healthcare policies are outside of its scope, the model aims to streamline existing donation processes. This paper emphasizes the need for a 'vein-to-vein' system, which tracks blood from donor to recipient, managed by a single entity controlling the blood centre's data infrastructure. Though limitations exist due to incomplete control over the transfusion chain, future work will demonstrate the model's application, focusing on areas like scheduling and monitoring pre-donation haemoglobin levels for better optimization. Comprehensive tracking, including of the recipient, is essential for full system optimization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.